CLOV Aims to Develop a Superior Product

During the last session, 9M of Clover Health Investments, Corp.’s (NasdaqGS:CLOV) shares were traded. The stock closed at $7.38 per share indicating that it lost -$0.16 or -2.25% during that day which brings the Clover Health Investments, Corp.’s valuation to $1.87B.

The 52-week high for the Clover Health Investments, Corp.’s shares is $28.85. That puts it -74.42% from that peak but still a fine gain since the share price dropped to a 52-week low of $6.31, while the S&P 500’s share price change was of 31%.

Advertisements

What does the trading volume tell us about the CLOV stock?

During the last trading session, Clover Health Investments, Corp. (NasdaqGS:CLOV) has seen growth in its daily volume. The daily volume was of 24M, while in the last 10 days the average was 10.78M and last three months – 23.29M.

Growing short interest

The Clover Health Investments, Corp.’s shares are seeing an increasing short interest compared to the previous month. As of today, there are 31.02M shares being shorted which translates into 0.98 of a short ratio for CLOV, while in the previous month the shorted shares were 30.27M.

Clover Health Investments, Corp. (NasdaqGS:CLOV)’s financials

With a market cap of $1.87B, Clover Health Investments, Corp. holds total cash of $607.15M that translates into $1.48 per share, while the total debt is of $29.14M.

The company has seen an increase in revenue with a year-over-year quarterly revenue growth percentage of 109.70%. The current revenue is of $921.74M that is $4.69 per share.


This is a great sign for a bright future.

One thought on “CLOV Aims to Develop a Superior Product

  1. Things I consider before buying a stock is whether there has been recent hedge activity or insider trading. CLOV isn’t among the top 30 hedge fund positions nor have insiders bought shares. The Return on Equity is -67.09%. I like stocks that return at least 14%. Momentum is also negative at -26.93%. News sentiment has been neutral and the analysts’ consensus is “Sell”.

    Like

Comments are closed.